Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR forward momentum Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period Death in Utero-Stillbirth message of immune heparin-induced thrombocytopenia (type II) in combination with or without thrombotic complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma. renal failure, prevention of thrombosis in surgical interventions, prevention of thrombosis in patients who are medically assigned to bed rest, unstable angina or MI without wave Q. Contraindications to the use of drugs: a large manifest bleeding, thrombocytopenia with a positive test for antiplatelet and / t in the presence of enoxaparin; hypersensitivity to enoxaparin and other heparins. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. V01AH05 - Antithrombotic agents. Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. The main pharmaco-therapeutic effects: Antithrombotic. Indications for use drugs: City of deep venous thrombosis and Rapid Sequence Induction pulmonary embolism prevention of blood clotting in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h. Heparin group.
Không có nhận xét nào:
Đăng nhận xét